Medlive Technology Co., Ltd.

HK$6.58As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2192Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 5Y CAGR (23.53%)
Div yield 4.61%
ROE 7.29%
Health Information Services
Beta (5Y) 0.53
PE TTM 12.32
TSR TTM (34.94%)
Mkt cap HK$4.870B
ROIC 8.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$7.34
11.58%
(25.89%)
Buy 6|0|3|2|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.10
0.09
0.10
0.09
6.37%
6.69%
6.75%
(3.52%)
Revenue¥M
328.6
323.5
317.5
311.2
3.73%
2.11%
(1.17%)
(3.70%)
Peers (US$621.2M)
Cap (US$)
PE
374.7M
36.55x
611.6M
—
Capital
TTM
5Y
10Y
Leveragex
8.412
0.594
0.454
EBIT/Intx
0.357
0.455
0.439
Own earn%
(625.10)
192.32
178.57
Sh yield%
18.21
23.97
25.19
Owners
Insiders/Inst%
14.28
50.32
Short interest%
5.08
SBC / revenue%
0.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
16–24
$1 testx
—
Incr. ROIC%
5